Rhythm Pharmaceuticals, Inc 10-K for FY2024
Rhythm Pharmaceuticals, Inc. (RYTM)
10-K
2025-02-28
For: 2024-12-31
View Original
Added on
April 08, 2026
About this 10-K
Rhythm Pharmaceuticals, Inc filed this 10-K on February 28, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $130.13M
- up 68.1% from $77.43M a year earlier
- Net loss
- $260.6M
- compared with a net loss of $184.68M a year earlier
- Diluted EPS
- -$4.34
- compared with -$3.20 a year earlier